Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delayed-Release UDCA in T2DM
NCT02033876Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2013
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in type 2 diabetes mellitus (T2DM), sponsored by Mayo Clinic. Started Oct 2013; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02033876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033876.